415 related articles for article (PubMed ID: 11014213)
1. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
Stoica A; Pentecost E; Martin MB
Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
[TBL] [Abstract][Full Text] [Related]
2. Effects of selenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
Stoica A; Pentecost E; Martin MB
J Cell Biochem; 2000 Aug; 79(2):282-92. PubMed ID: 10967555
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-like activity of metals in MCF-7 breast cancer cells.
Martin MB; Reiter R; Pham T; Avellanet YR; Camara J; Lahm M; Pentecost E; Pratap K; Gilmore BA; Divekar S; Dagata RS; Bull JL; Stoica A
Endocrinology; 2003 Jun; 144(6):2425-36. PubMed ID: 12746304
[TBL] [Abstract][Full Text] [Related]
4. Effects of tobacco smoke condensate on estrogen receptor-alpha gene expression and activity.
Martin MB; Reiter R; Johnson M; Shah MS; Iann MC; Singh B; Richards JK; Wang A; Stoica A
Endocrinology; 2007 Oct; 148(10):4676-86. PubMed ID: 17640996
[TBL] [Abstract][Full Text] [Related]
5. Activation of estrogen receptor-alpha by the heavy metal cadmium.
Stoica A; Katzenellenbogen BS; Martin MB
Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
[TBL] [Abstract][Full Text] [Related]
6. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
10. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
11. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells.
Garcia-Morales P; Saceda M; Kenney N; Kim N; Salomon DS; Gottardis MM; Solomon HB; Sholler PF; Jordan VC; Martin MB
J Biol Chem; 1994 Jun; 269(24):16896-901. PubMed ID: 8207012
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.
Han WD; Mu YM; Lu XC; Xu ZM; Li XJ; Yu L; Song HJ; Li M; Lu JM; Zhao YL; Pan CY
Endocr Relat Cancer; 2003 Jun; 10(2):217-24. PubMed ID: 12790785
[TBL] [Abstract][Full Text] [Related]
13. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
Kraus WL; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
[TBL] [Abstract][Full Text] [Related]
15. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.
Hall JM; Korach KS
Mol Endocrinol; 2003 May; 17(5):792-803. PubMed ID: 12586845
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells.
Stoner M; Saville B; Wormke M; Dean D; Burghardt R; Safe S
Mol Endocrinol; 2002 Oct; 16(10):2231-42. PubMed ID: 12351689
[TBL] [Abstract][Full Text] [Related]
17. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells.
Cavaillès V; Gompel A; Portois MC; Thénot S; Mabon N; Vignon F
J Mol Endocrinol; 2002 Jun; 28(3):165-75. PubMed ID: 12063183
[TBL] [Abstract][Full Text] [Related]
18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
19. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
20. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
